• Fernandez Villalobos NV, Kessel B, Torres Paez JC, Strömpl J, Kerrinnes T, de la Hoz Restrepo FP, Strengert M, Krause G (2023) Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogota: An explorative cross-sectional study. Front Public Health 11(n/a): 981172.

    • Fernandez Villalobos NV, Marsall P, Torres Paez JC, Strompl J, Gruber J, Lotto Batista M, Pohl D, Concha G, Frickmann H, de la Hoz Restrepo FP, Schneiderhan-Marra N, Krause G, Dulovic A, Strengert M, Kann S (2023) Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia. Commun Med (Lond) 3(1): 151.

    • Hassenstein MJ, Pischon T, Karch A, Peters A, Kerrinnes T, Teismann H, Schneider A, Thierry S, Moreno Velasquez I, Janke J, Kemmling Y, Castell S (2023) Seropositivity of Borrelia burgdorferi s.l. in Germany---an analysis across four German National Cohort (NAKO) study sites. Sci Rep 13(1): 21087.

    • Junker D, Becker M, Wagner TR, Kaiser PD, Maier S, Grimm TM, Griesbaum J, Marsall P, Gruber J, Traenkle B, Heinzel C, Pinilla YT, Held J, Fendel R, Kreidenweiss A, Nelde A, Maringer Y, Schroeder S, Walz JS, Althaus K, Uzun G, Mikus M, Bakchoul T, Schenke-Layland K, Bunk S, Haeberle H, Gopel S, Bitzer M, Renk H, Remppis J, Engel C, Franz AR, Harries M, Kessel B, Lange B, Strengert M, Krause G, Zeck A, Rothbauer U, Dulovic A, Schneiderhan-Marra N (2023) Antibody binding and ACE2 binding inhibition is significantly reduced for both the BA1 and BA2 omicron variants. Clin Infect Dis 76(3): e240-e249.

    • Kettlitz R, Harries M, Ortmann J, Krause G, Mu SpadTeam, Aigner A, Lange B (2023) Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany. BMC Public Health 23(1): 2281.


    • Becker M, Cossmann Anne, Lurken K, Junker D, Gruber J, Juengling J, Ramos GM, Beigel A, Wrenger E, Lonnemann G, Stankov MV, Dopfer-Jablonka A, Kaiser PD, Traenkle B, Rothbauer U, Krause Gerard, Schneiderhan-Marra N, Strengert M, Dulovic A, Behrens GMN (2022) Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients. Front Immunol 13(n/a): 1004045.

    • Coors A, Hassenstein MJ, Krause G, Kerrinnes T, Harries M, Breteler MMB, Castell S (2022) Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany. Parasit Vectors 15(1): 214.

    • Dulovic A, Kessel B, Harries M, Becker M, Ortmann J, Griesbaum J, Jüngling J, Junker D, Hernandez P, Gornyk D, Glöckner S, Melhorn V, Castell S, Heise JK, Kemmling Y, Tonn T, Frank K, Illig T, Klopp N, Warikoo N, Rath A, Suckel C, Marzian AU, Grupe N, Kaiser PD, Traenkle B, Rothbauer U, Kerrinnes T, Krause G, Lange B, Schneiderhan-Marra N, Strengert M (2022) Comparative magnitude and persistence of humoral SARS-CoV-2 vaccination responses in the adult population in Germany. Front Immunol 13(n/a).

    • Fernandez Villalobos NV, Kessel B, Rodiah I, Ott JJ, Lange B, Krause G (2022) Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis. PLoS One 17(6): 1-22.

    • Hassenstein MJ, Janzen I, Krause G, Harries M, Melhorn V, Kerrinnes T, Kemmling Y, Castell S (2022) Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover. Microorganisms 10(11): 2286.

    • Heinsohn T, Lange B, Vanella P, Rodiah I, Glöckner S, Joachim A, Becker D, Brändle T, Dhein S, Ehehalt S, Fries M, Galante-Gottschalk A, Jehnichen S, Kolkmann S, Kossow A, Hellmich M, Dötsch J, Krause G (2022) Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data. PLoS Medicine 19(12): e1003913.

    • Jacobsen H, Strengert M, Maass H, Durand MAY, Katzmarzyk M, Kessel B, Harries M, Rand U, Abassi L, Kim Y, Lüddecke T, Metzdorf K, Hernandez P, Ortmann J, Heise J, Castell S, Gornyk D, Glöckner S, Melhorn V, Kemmling Y, Lange B, Dulovic A, Marsall P, Häring J, Junker D, Schneiderhan-Marra N, Hoffmann M, Pöhlmann S, Krause G, Cicin-Sain L (2022) Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations. Scientific Reports 12(1): 19858.

    • Umutesi J, Nsanzimana S, Yingkai Liu C, Vanella P, Ott JJ, Krause G (2022) Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting. BMC Infect Dis 22(1): 500.


    • Becker M, Dulovic A, Junker D, Ruetalo N, Kaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M, Schneiderhan-Marra N (2021) Immune response to SARS-CoV-2 variants of concern in vaccinated individuals. Nat Commun 12(1): 3109.

    • Becker M, Strengert M, Junker D, Kaiser PD, Kerrinnes T, Traenkle B, Dinter H, Haring J, Ghozzi S, Zeck A, Weise F, Peter A, Horber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Marklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause G, Schneiderhan-Marra N (2021) Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity. Nat Commun 12(1): 1152.

    • Concha G, Frickmann H, Oey A, Strengert M, Kreienbrock L, Kann S (2021) Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia-A Cross-Sectional Assessment Providing Preliminary Surveillance Data. Vaccines 9(10): 1120.

    • Fernandez Villalobos NV, Ott JJ, Klett-Tammen CJ, Bockey A, Vanella P, Krause G, Lange B (2021) Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis. Syst Rev 10(1): 194.

    • Fink S, Ruoff F, Stahl A, Becker M, Kaiser P, Traenkle B, Junker D, Weise F, Ruetalo N, Hörber S, Peter A, Nelde A, Walz J, Krause G, Baillot A, Schenke-Layland K, Joos TO, Rothbauer U, Schneiderhan-Marra N, Schindler M, Templin MF (2021) Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2. ACS Infect Dis 7(6): 1596-1606.

    • Lohrmann F, Berg A, Wicker E, Imm A, Krause G, Zürn K, Berner R, Hufnagel M, Lander F (2021) Prevalence of Capsular Serotype, Pilus Island Distribution, and Antibiotic Resistance in Pediatric and Adult Invasive Group B Streptococcus Isolates. Pediatr Infect Dis J 40(1): 76-82.

    • Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanovi S, Rammensee HG, Walz JS (2021) SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat Immunol 22(1): 74-85.

    • Strengert M, Becker M, Ramos GM, Dulovic A, Gruber J, Juengling J, Lürken K, Beigel A, Wrenger E, Lonnemann G, Cossmann A, Stankov MV, Dopfer-Jablonka A, Kaiser PD, Traenkle B, Rothbauer U, Krause G, Schneiderhan-Marra N, Behrens GMN (2021) Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis. EBioMedicine 70(n/a): 103524.

    • Wagner TR, Ostertag E, Kaiser PD, Gramlich M, Ruetalo N, Junker D, Haering J, Traenkle B, Becker M, Dulovic A, Schweizer H, Nueske S, Scholz A, Zeck A, Schenke-Layland K, Nelde A, Strengert M, Walz JS, Zocher G, Stehle T, Schindler M, Schneiderhan-Marra N, Rothbauer U (2021) NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies. EMBO Rep 22(5): e52325.


    • Bohm K, Strompl J, Krumbholz A, Zell R, Krause G, Sievers C (2020) Establishment of a highly sensitive assay for detection of Hepatitis E virus-specific immunoglobulins. J Clin Microbiol 58(2).


    • Grylka-Baeschlin S, Clarke M, Begley C, Daly D, Healy P, Nicoletti J, Devane D, Morano S, Krause G, Karch A, Savage G, Gross MM (2019) Labour characteristics of women achieving successful vaginal birth after caesarean section in three European countries. Midwifery 74:(n/a): 36-43.

    • Wicker E, Lander F, Weidemann F, Hufnagel M, Berner R, Krause G (2019) Group B Streptococci: Declining Incidence in Infants in Germany. Pediatr Infect Dis J 38(5): 516-519.


    • Bohm K, Krause G, Sievers C (2018) Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine 36(27): 3885.

    • Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, Glockner S, Krause G, Stiesch M (2018) Epidemiology and risk factors of peri-implantitis: A systematic review. J Periodontal Res 53(5): 657-681.


    • Bohm K, Filomena A, Schneiderhan-Marra N, Krause G, Sievers C (2017) Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine 35(43): 5883--5889.